More Inventiva Sa news
Inventiva SaEURONEXT: IVA

Inventiva annonce la dernière visite du dernier patient de l’étude clinique de Phase 3 NATiV3 évaluant le lanifibranor dans la MASH

Sep 1, 2026 at 10:00 PM UTC · Issued by Inventiva SA via Euronext
Watch Inventiva Sa explain it↗Inventiva S.A. (IVA) Q1 2026 Earnings Call · Replay · Apr 28

Inventiva Sa has released a press release.

View Attachment

Company analysis

Earlier from Inventiva Sa

  • Inventiva Appoints Chris Benecchi as Chief Operating OfficerAug 31
  • Inventiva nomme Chris Benecchi au poste de Chief Operating OfficerAug 30
  • Correction: Inventiva Announces Preliminary Financial Results for the First Half of 2026¹Jul 30
  • Inventiva Announces Preliminary Financial Results for the First Half of 2026¹Jul 29
All Inventiva Sa news releases↗